Freightos (CRGO) CMO discloses stock options and RSU grants

Rhea-AI Filing Summary

Freightos Ltd Chief Marketing Officer Eytan Buchman filed an initial Form 3 reporting his equity holdings in the company. The filing lists directly held ordinary shares and multiple tranches of stock options to buy ordinary shares at exercise prices between 0.8500 and 4.1700 with expirations from 2027 to 2032, along with restricted share units that vest on scheduled dates through 2027.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Buchman Eytan

(Last) (First) (Middle)

C/O FREIGHTOS LIMITED, PLANTA 10

AVDA. DIAGONAL, 211

(Street)

BARCELONA 08018

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]

3a. Foreign Trading Symbol
[N/A]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	2,000	D
Ordinary shares(1)	31,270	D
Ordinary shares(2)	35,730	D
Ordinary shares(3)	37,500	D
Ordinary shares(4)	37,500	D
Ordinary shares(5)	36,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock options (right to buy)	01/01/2021	01/23/2027	Ordinary shares	590	$0.85	D
Stock options (right to buy)	07/01/2021	07/14/2027	Ordinary shares	14,073	$0.85	D
Stock options (right to buy)	01/01/2023	01/21/2029	Ordinary shares	34,681	$1.07	D
Stock options (right to buy)	01/01/2024	01/12/2030	Ordinary shares	35,181	$1.07	D
Stock options (right to buy)	07/15/2024	07/14/2030	Ordinary shares	125,595	$1.45	D
Stock options (right to buy)	01/01/2026	02/17/2032	Ordinary shares	94,988	$4.17	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted to the Reporting Person by the Issuer which began vesting (and settling for underlying ordinary shares) on July 15, 2023 in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.

2. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer which began vesting (and settling for underlying ordinary shares) on July 15, 2024 in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.

3. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer which began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.

4. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer which began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.

5. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer which began vesting (and settling for underlying ordinary shares) on July 15, 2025 in accordance with the following schedule: 33.33% of the RSUs will vest upon the one-year anniversary of the vesting commencement date and the remaining RSUs will vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney.

	/s/ Michael Oberlander, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Freightos (CRGO) Form 3 filing by Eytan Buchman report?

The Form 3 reports Chief Marketing Officer Eytan Buchman’s initial equity holdings in Freightos Ltd, including ordinary shares, stock options, and restricted share units. It establishes his beneficial ownership position as an officer at the time he became subject to reporting requirements.

What stock options does Freightos (CRGO) CMO Eytan Buchman hold according to the Form 3?

The filing shows several grants of stock options to buy ordinary shares with exercise prices of 0.8500, 1.0700, 1.4500, and 4.1700, expiring between 2027 and 2032. These options represent potential future share ownership if exercised.

How are Eytan Buchman’s restricted share units in Freightos (CRGO) scheduled to vest?

The ordinary shares in several rows represent RSUs that began vesting on July 15, 2023, July 15, 2024, March 13, 2025, and July 15, 2025. Some vest one-third after one year then quarterly over eight quarters, others vest fully by December 31, 2026 or December 31, 2027.

Does the Freightos (CRGO) Form 3 show any recent buy or sell transactions by Eytan Buchman?

No buy or sell activity is reported. The entries are categorized as holdings, with transaction codes marked as unknown and the transaction summary showing zero buys, zero sells, and a neutral net buy/sell direction, indicating this is strictly an initial ownership snapshot.

Are Eytan Buchman’s Freightos (CRGO) holdings reported as direct or indirect ownership?

All listed positions in the data are reported as direct ownership, with ownership codes marked “D” and no nature-of-ownership footnotes indicating trusts, LLCs, or other entities. This means the holdings are attributed directly to the reporting person himself.

What is the significance of the expiration dates on Freightos (CRGO) stock options held by Eytan Buchman?

Each option grant lists a specific expiration date between 2027 and 2032. Buchman can only exercise these rights to buy ordinary shares before their respective expirations; after those dates, any unexercised options lapse and no longer provide purchase rights.